To begin to explore the prostate-specific expression of PCA3, we evaluated publically available The Cancer Genome Atlas (TCGA) data finding that while PCA3 was expressed in very few samples from other cancers, it was most abundant in prostate cancer (Figure 1A). This evidence concerns the gene PCA3 and Familial prostate cancer.